Lucas Nivon
InvestorVenture Partner at Argonautic Ventures
Seattle, Washington
Writes $100K – $5M checks · typically $1.5M
Find your path to Lucas
631 people in our graph share verified history with Lucas — schools, employers, funds. One of them is your warm intro.
About
Lucas Nivon is co-founder and executive committee member at OpenFold, where he leads the Cyrus team in discovering new biologic drugs through computational algorithms and large-scale wet lab screening. With training in computational biophysics, he oversees development of protein-based therapeutics including CYR212, a candidate for IgG-mediated autoimmune diseases, alongside programs in pulmonary disease and inflammatory gut disorders. Cyrus, spun out of the University of Washington in 2015, has raised over $35 million and collaborates with partners including Janssen, the Broad Institute, and numerous academic and industry organizations.
Experience
- OpenFoldCo-Founder and Executive Committee Membercurrent2022 — present
- Cyrus BiotechnologyCEO and Co-Foundercurrent2014 — presentSeattle, WA
- Argonautic VenturesVenture Partnercurrent2022 — present
- University of WashingtonTranslational Investigator2014 — 2015Seattle, WA
- University of WashingtonPost-Doctoral Fellow2008 — 2014
- PedalAnywhereCo-Founder2012 — 2015Seattle, WA
- Harvard UniversityAssistant Resident Dean and Resident Tutor2003 — 2007
- ETH ZurichVisiting Graduate Student2001 — 2002
Skills & more
+12 more
Protein-protein InteractionsMolecular CloningBusiness StrategyEntrepreneurshipMolecular BiologyBusiness DevelopmentLife SciencesResearchC/C++, perlProtein Biochemistry, Mass SpecSingle-molecule spectroscopyCell CultureLanguages German · Spanish
From Lucas's professional profile.
Colleagues at Argonautic Ventures
Network2
Investors connected to Lucas in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Lucas Nivon?
- Lucas Nivon is co-founder and executive committee member at OpenFold, where he leads the Cyrus team in discovering new biologic drugs through computational algorithms and large-scale wet lab screening. With training in computational biophysics, he oversees development of protein-based therapeutics including CYR212, a candidate for IgG-mediated autoimmune diseases, alongside programs in pulmonary disease and inflammatory gut disorders. Cyrus, spun out of the University of Washington in 2015, has raised over $35 million and collaborates with partners including Janssen, the Broad Institute, and numerous academic and industry organizations.
- Where does Lucas Nivon work?
- Lucas Nivon is Venture Partner at Argonautic Ventures.
- What check size does Lucas Nivon write?
- Lucas Nivon typically writes checks of $100K – $5M.
- Where did Lucas Nivon go to school?
- Lucas Nivon studied at Harvard University (PhD, Biophysics); Harvard University (AB, Biochemistry); Hunter College High School.
Founder mafias
Hunter College High School mafia7
Also came through, then founded or led a company.
Argonautic Ventures mafia2
Also came through, then founded or led a company.
Same school
Also attended Harvard University2,000
+ 1,994 more
Also attended Hunter College High School18
+ 12 more
Shared employers
Also worked at OpenFold1
Also worked at Cyrus Biotechnology4
Also worked at University of Washington170
+ 164 more
Also worked at Harvard University423
+ 417 more